Anemia in chronic heart failure--clinical and prognostic significance.

T Karhausen, Stefan D Anker, W Doehner
{"title":"Anemia in chronic heart failure--clinical and prognostic significance.","authors":"T Karhausen,&nbsp;Stefan D Anker,&nbsp;W Doehner","doi":"10.2174/156801605774322300","DOIUrl":null,"url":null,"abstract":"<p><p>Anemia is a common finding in chronic heart failure (CHF). Anemia develops due to CHF, but is also known to cause heart failure. Patients with CHF are limited by exercise capacity and fatigue. Low hemoglobin concentration can account for both and may substantially contribute to the symptoms of CHF. Increasing severity of CHF is associated with a higher frequency of anemia, which also becomes clinically more relevant. Anemia has been shown to predict impaired survival in CHF, independent of established prognostic markers. There are many potential reasons for development of anemia in CHF, such as bone marrow depression, reduced intestinal iron uptake and hemodilution as a consequence of sodium and water retention. In most cases, however, anemia in CHF should be viewed as \"anemia of chronic illness\", being the result of a combination of many factors related to the disease, particularly chronic inflammation. The option of therapeutically targeting anemia in CHF is an intriguing novel approach to improve morbidity and potentially mortality in these patients.</p>","PeriodicalId":87078,"journal":{"name":"Current medicinal chemistry. Cardiovascular and hematological agents","volume":"3 4","pages":"297-303"},"PeriodicalIF":0.0000,"publicationDate":"2005-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/156801605774322300","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current medicinal chemistry. Cardiovascular and hematological agents","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/156801605774322300","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

Anemia is a common finding in chronic heart failure (CHF). Anemia develops due to CHF, but is also known to cause heart failure. Patients with CHF are limited by exercise capacity and fatigue. Low hemoglobin concentration can account for both and may substantially contribute to the symptoms of CHF. Increasing severity of CHF is associated with a higher frequency of anemia, which also becomes clinically more relevant. Anemia has been shown to predict impaired survival in CHF, independent of established prognostic markers. There are many potential reasons for development of anemia in CHF, such as bone marrow depression, reduced intestinal iron uptake and hemodilution as a consequence of sodium and water retention. In most cases, however, anemia in CHF should be viewed as "anemia of chronic illness", being the result of a combination of many factors related to the disease, particularly chronic inflammation. The option of therapeutically targeting anemia in CHF is an intriguing novel approach to improve morbidity and potentially mortality in these patients.

慢性心力衰竭患者贫血的临床和预后意义
贫血是慢性心力衰竭(CHF)的常见症状。贫血是由心力衰竭引起的,但也会导致心力衰竭。慢性心力衰竭患者受到运动能力和疲劳的限制。低血红蛋白浓度可以解释这两种情况,并可能在很大程度上导致慢性心力衰竭的症状。CHF严重程度的增加与贫血的高频率相关,这在临床上也变得更加相关。贫血已被证明可预测CHF患者的生存受损,独立于已建立的预后标志物。CHF患者发生贫血的潜在原因有很多,如骨髓抑制、肠道铁摄取减少以及钠和水潴留导致的血液稀释。然而,在大多数情况下,CHF中的贫血应被视为“慢性病贫血”,是与该疾病相关的许多因素(特别是慢性炎症)共同作用的结果。针对CHF患者贫血的治疗选择是一种有趣的新方法,可以改善这些患者的发病率和潜在死亡率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信